Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06955130
NA

Lactate and Glycerol Contribution to Gluconeogenesis

Sponsor: Rutgers, The State University of New Jersey

View on ClinicalTrials.gov

Summary

A major cause of increased blood glucose levels in type 2 diabetes (T2D) is increased hepatic gluconeogenesis (GNG), as the liver converts various substrates into glucose. Two of these substrates include glycerol, a molecule from fat, and lactate, a molecule that circulates in the blood. Our previously collected data suggest that glycerol's role in this process has been underestimated, so the investigators will directly compare the carbon contribution of glycerol and lactate to new glucose production under fasting conditions in patients with and without T2D. The investigators will also assess how glucagon, a hormone that raises blood glucose levels, impacts the conversion of glycerol and lactate to glucose. Enrolled participants will undergo three separate isotope tracer infusions with serial blood collections for liquid chromatography-mass spectrometry analysis. This research could identify new therapeutic drug targets that can lower blood glucose levels more directly and effectively.

Key Details

Gender

All

Age Range

40 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2026-07-01

Completion Date

2030-04-30

Last Updated

2025-12-02

Healthy Volunteers

Yes

Interventions

DRUG

Glycerol

Subjects will receive an infusion of glycerol and glucagon.

DRUG

Lactate

Subjects will receive an infusion of lactate and glucagon.

DRUG

Glucose

Subjects will receive an infusion of glucose and glucagon.